Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 5, 2002, Pages 1557-1560

  Mueller, Silke C ^a   Majcher Peszynska, Jolanta ^a   Hickstein, Heiko ^a   Francke, Astrid ^a   Pertschy, Annette ^a   Schulz, Martin ^a   Mundkowski, Ralf ^a   Drewelow, Bernd ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TAZOBACTAM;

ADULT; AGED; ANURIA; ARTICLE; CLINICAL ARTICLE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDUCED DISEASE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INTENSIVE CARE; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANURIA; DRUG THERAPY, COMBINATION; HUMANS; INTENSIVE CARE UNITS; MALE; PENICILLANIC ACID; PIPERACILLIN; RENAL DIALYSIS;

EID: 0036237031     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.5.1557-1560.2002     Document Type: Article

References (21)

1. Piperacillin and tazobactam exhibit linear pharmacokinetics after multiple standard clinical doses
2. Piperacillin-tazobactam: A new β-lactam-β-lactamase inhibitor combination
3. Pharmacokinetics of piperacillin, tazobactam and its metabolite in renal impairment
4. Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairment
5. A primer on continuous renal replacement therapy for critically ill patients
6. Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients
7. Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam
8. Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration
9. Principles of drug administration in renal insufficiency
10. Importance of β-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor-drug combinations: Studies with piperacillin-tazobactam and piperacillin-sulbactam
11. Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography
12. Pharmacokinetics and pharmacodynamics of two multiple-dose piperacillin-tazobactam regimens
13. Piperacillin/tazobactam: An updated review of its use in the treatment of bacterial infections
14. High-performance liquid chromatographic determination of tazobactam by precolumn derivatization
15. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations
16. Piperacillin/tazobactam: A critical review of the evolving clinical literature
17. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. Conference report
18. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration
19. Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure treated with continuous veno-venous hemofiltration (CVVH)